Browsing by Author "Cakar, B."
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?(2019-01-01) Olmez, O. F.; Bilici, A.; Gursoy, P.; Cubukcu, E.; Yildiz, O.; Sakin, A.; Korkmaz, T.; Cil, I.; Cakar, B.; Menekse, S.; Demir, T.; Acikgoz, O.; Hamdard, J.Item Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer(2019-01-01) Bilici, A.; Olmez, O. F.; Gursoy, P.; Cubukcu, E.; Yildiz, O.; Sakin, A.; Korkmaz, T.; Cil, I.; Cakar, B.; Menekse, S.; Demir, T.; Acikgoz, O.; Hamdard, J.Item Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey(ELSEVIER, 2021-01-01) Sendur, M. A. N.; Cakar, B.; Hizal, M.; Eraslan, E.; Aksoy, S.; Paydas, S.; Demir, N.; Sen, F.; Bulut, G.; Oruc, K.; Uluc, B. Oyan; Ozdemir, N.; Sakin, A.; Erdem, D.; Ozkan, M.; Disel, U.; Ekinci, F.; Okten, I. N.; Ozer, L.; Gokmen, E.